Ansell Limited (ANSLY)
USD 71.79
(0.0%)
USD 71.79
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 624.8 Million USD | 3.41% |
| 2023 | 604.22 Million USD | -3.35% |
| 2022 | 625.18 Million USD | -22.55% |
| 2021 | 807.2 Million USD | 24.6% |
| 2020 | 647.86 Million USD | 14.81% |
| 2019 | 564.29 Million USD | 3.2% |
| 2018 | 546.8 Million USD | 1.72% |
| 2017 | 537.55 Million USD | 1.63% |
| 2016 | 528.93 Million USD | -0.08% |
| 2015 | 529.34 Million USD | -12.44% |
| 2014 | 604.54 Million USD | 27.61% |
| 2013 | 473.74 Million USD | -8.53% |
| 2012 | 517.91 Million USD | -4.53% |
| 2011 | 542.49 Million USD | 48.05% |
| 2010 | 366.43 Million USD | 9.12% |
| 2009 | 335.82 Million USD | -25.05% |
| 2008 | 448.06 Million USD | 36.54% |
| 2007 | 328.14 Million USD | 41.98% |
| 2006 | 231.12 Million USD | -10.27% |
| 2005 | 257.58 Million USD | 16.04% |
| 2004 | 221.98 Million USD | 4.76% |
| 2003 | 211.89 Million USD | -8.6% |
| 2002 | 231.84 Million USD | -64.24% |
| 2001 | 648.41 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 4.6 Billion USD | -9.73% |
| 1996 | 5.1 Billion USD | -1.94% |
| 1995 | 5.2 Billion USD | 2.66% |
| 1994 | 5.07 Billion USD | 19.97% |
| 1993 | 4.22 Billion USD | -2.27% |
| 1992 | 4.32 Billion USD | 14.63% |
| 1991 | 3.77 Billion USD | -5.29% |
| 1990 | 3.98 Billion USD | 16.83% |
| 1989 | 3.41 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 620.6 Million USD | 2.71% |
| 2024 Q4 | 322.78 Million USD | 97.91% |
| 2024 Q3 | 163.1 Million USD | -44.97% |
| 2024 Q2 | 296.4 Million USD | 98.53% |
| 2024 Q1 | 149.3 Million USD | -51.51% |
| 2023 FY | 604.22 Million USD | -3.35% |
| 2023 Q1 | 152.8 Million USD | -55.09% |
| 2023 Q2 | 302.8 Million USD | 98.17% |
| 2023 Q3 | 155.55 Million USD | -48.63% |
| 2023 Q4 | 307.87 Million USD | 97.92% |
| 2022 FY | 625.18 Million USD | -22.55% |
| 2022 Q4 | 340.21 Million USD | 0.0% |
| 2022 Q2 | 322.2 Million USD | 0.0% |
| 2021 Q4 | 413.66 Million USD | 0.0% |
| 2021 FY | 807.2 Million USD | 24.6% |
| 2021 Q2 | 374.2 Million USD | 0.0% |
| 2020 Q2 | 292.1 Million USD | 0.0% |
| 2020 Q4 | 325.43 Million USD | 0.0% |
| 2020 FY | 647.86 Million USD | 14.81% |
| 2019 Q4 | 305.64 Million USD | 0.0% |
| 2019 FY | 564.29 Million USD | 3.2% |
| 2019 Q2 | 390.84 Million USD | 0.0% |
| 2018 Q2 | 349.33 Million USD | 0.0% |
| 2018 FY | 546.8 Million USD | 1.72% |
| 2018 Q4 | 418.97 Million USD | 0.0% |
| 2017 Q2 | 361.27 Million USD | 0.0% |
| 2017 FY | 537.55 Million USD | 1.63% |
| 2017 Q4 | 364.95 Million USD | 0.0% |
| 2016 Q2 | 431.44 Million USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | 528.93 Million USD | -0.08% |
| 2015 Q4 | 442.94 Million USD | 0.0% |
| 2015 Q2 | 440.42 Million USD | 0.0% |
| 2015 FY | 529.34 Million USD | -12.44% |
| 2014 Q1 | 131.31 Million USD | -60.93% |
| 2014 Q2 | 336.78 Million USD | 156.47% |
| 2014 Q3 | 157.75 Million USD | -53.16% |
| 2014 FY | 604.54 Million USD | 27.61% |
| 2014 Q4 | 385.75 Million USD | 144.53% |
| 2013 Q4 | 336.11 Million USD | 129.46% |
| 2013 FY | 473.74 Million USD | -8.53% |
| 2013 Q1 | 130.01 Million USD | 0.0% |
| 2013 Q2 | 146.45 Million USD | 12.65% |
| 2013 Q3 | 146.48 Million USD | 0.02% |
| 2012 Q2 | 133.85 Million USD | 15.82% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 517.91 Million USD | -4.53% |
| 2012 Q1 | 115.57 Million USD | 0.0% |
| 2012 Q3 | 129.97 Million USD | -2.9% |
| 2011 Q1 | 123.84 Million USD | 0.0% |
| 2011 FY | 542.49 Million USD | 48.05% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 122.66 Million USD | 3.95% |
| 2011 Q2 | 118 Million USD | -4.71% |
| 2010 FY | 366.43 Million USD | 9.12% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 117.59 Million USD | 3.18% |
| 2010 Q1 | 113.4 Million USD | 0.0% |
| 2010 Q2 | 113.96 Million USD | 0.49% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | 335.82 Million USD | -25.05% |
| 2009 Q1 | 94 Million USD | 0.0% |
| 2009 Q2 | 84.23 Million USD | -10.39% |
| 2009 Q3 | 92.15 Million USD | 9.4% |
| 2008 FY | 448.06 Million USD | 36.54% |
| 2008 Q3 | 111.86 Million USD | 2.02% |
| 2008 Q2 | 109.64 Million USD | 8.83% |
| 2008 Q1 | 100.75 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 78.97 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 92.35 Million USD | 4.45% |
| 2007 Q2 | 88.41 Million USD | 11.95% |
| 2007 FY | 328.14 Million USD | 41.98% |
| 2006 FY | 231.12 Million USD | -10.27% |
| 2006 Q1 | 84.75 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 79.21 Million USD | -6.54% |
| 2006 Q3 | 75.04 Million USD | -5.26% |
| 2005 Q1 | 81.43 Million USD | 0.0% |
| 2005 FY | 257.58 Million USD | 16.04% |
| 2005 Q2 | 86.26 Million USD | 5.93% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 85.92 Million USD | -0.39% |
| 2004 FY | 221.98 Million USD | 4.76% |
| 2004 Q2 | 86.46 Million USD | 9.37% |
| 2004 Q1 | 79.05 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 85.66 Million USD | -0.93% |
| 2003 FY | 211.89 Million USD | -8.6% |
| 2003 Q2 | 68.03 Million USD | -31.42% |
| 2003 Q1 | 99.21 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q3 | 69.5 Million USD | 2.16% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q3 | 96.86 Million USD | 4.45% |
| 2002 FY | 231.84 Million USD | -64.24% |
| 2002 Q1 | 155.19 Million USD | 0.0% |
| 2002 Q2 | 92.73 Million USD | -40.24% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | 648.41 Million USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 154.57 Million USD | -10.97% |
| 2001 Q2 | 173.63 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | 1.11 Billion USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 1.2 Billion USD | 2.31% |
| 1997 Q1 | 1.27 Billion USD | 0.2% |
| 1997 FY | 4.6 Billion USD | -9.73% |
| 1997 Q2 | 1.17 Billion USD | -7.85% |
| 1996 Q1 | 1.37 Billion USD | 5.73% |
| 1996 FY | 5.1 Billion USD | -1.94% |
| 1996 Q2 | 1.21 Billion USD | -11.79% |
| 1996 Q3 | 1.26 Billion USD | 4.06% |
| 1996 Q4 | 1.27 Billion USD | 1.03% |
| 1995 Q3 | 1.33 Billion USD | -3.37% |
| 1995 Q4 | 1.3 Billion USD | -2.34% |
| 1995 FY | 5.2 Billion USD | 2.66% |
| 1995 Q1 | 1.28 Billion USD | 1.58% |
| 1995 Q2 | 1.37 Billion USD | 7.09% |
| 1994 Q1 | 1.01 Billion USD | -3.57% |
| 1994 FY | 5.07 Billion USD | 19.97% |
| 1994 Q4 | 1.26 Billion USD | 3.49% |
| 1994 Q2 | 1.23 Billion USD | 21.18% |
| 1994 Q3 | 1.22 Billion USD | -0.8% |
| 1993 Q3 | 1.1 Billion USD | 3.72% |
| 1993 Q4 | 1.05 Billion USD | -4.5% |
| 1993 FY | 4.22 Billion USD | -2.27% |
| 1993 Q2 | 1.06 Billion USD | 2.64% |
| 1993 Q1 | 1.03 Billion USD | -3.88% |
| 1992 Q4 | 1.08 Billion USD | -2.8% |
| 1992 FY | 4.32 Billion USD | 14.63% |
| 1992 Q1 | 980.5 Million USD | 3.93% |
| 1992 Q2 | 1.08 Billion USD | 10.72% |
| 1992 Q3 | 1.11 Billion USD | 2.49% |
| 1991 Q3 | 952.88 Million USD | -1.11% |
| 1991 Q4 | 943.47 Million USD | -0.99% |
| 1991 Q2 | 963.57 Million USD | -7.76% |
| 1991 FY | 3.77 Billion USD | -5.29% |
| 1991 Q1 | 1.04 Billion USD | 4.87% |
| 1990 Q1 | 873.96 Million USD | 2.5% |
| 1990 Q2 | 971.41 Million USD | 11.15% |
| 1990 Q3 | 948.69 Million USD | -2.34% |
| 1990 Q4 | 996.14 Million USD | 5.0% |
| 1990 FY | 3.98 Billion USD | 16.83% |
| 1989 Q2 | 993.55 Million USD | 0.0% |
| 1989 FY | 3.41 Billion USD | 0.0% |
| 1989 Q4 | 852.64 Million USD | -7.21% |
| 1989 Q3 | 918.92 Million USD | -7.51% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -36672.257% |
| Ansell Limited | 624.8 Million USD | 0.0% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -448.349% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -462526.337% |
| Psykey, Inc. | 415.97 Thousand USD | -150100.973% |
| ConvaTec Group Plc | 1.2 Billion USD | 48.068% |
| ConvaTec Group Plc | 1.17 Billion USD | 46.816% |
| Encision Inc. | 3.13 Million USD | -19823.711% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -78588.888% |
| LifePoint, Inc. | -71.35 Thousand USD | 875685.078% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 477046.565% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -118909.524% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -103474.034% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -104658.216% |
| SmileDirectClub, Inc. | 275.84 Million USD | -126.502% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 30.634% |
| SheerVision, Inc. | 2.17 Million USD | -28614.436% |
| United Health Products, Inc. | -4857.00 USD | 12864007.762% |
| Vasamed, Inc. | -69.38 Thousand USD | 900543.881% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -233327.855% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1186559.576% |